SAMHD1 mutations in mantle cell lymphoma are recurrent and confer in vitro resistance to nucleoside analogues.
Bühler MM, Lu J, Scheinost S, Nadeu F, Roos-Weil D, Hensel M, Thavayogarajah T, Moch H, Manz MG, Haralambieva E, Marques Maggio E, Beà S, Giné E, Campo E, Bernard OA, Huber W, Zenz T.
Bühler MM, et al.
Leuk Res. 2021 Aug;107:106608. doi: 10.1016/j.leukres.2021.106608. Epub 2021 May 3.
Leuk Res. 2021.
PMID: 33979727
No abstract available.